Home » Topics » Regulatory » Patents

Patents
RSS

Shanghai Jiongshuo Pharmaceutical Technology identifies CDK9/cyclin T1 inhibitors

Nov. 12, 2018

Tempest Therapeutics discloses prostanoid EP4 receptor antagonists

Nov. 9, 2018

Neurocrine Biosciences presents SLC18A2 inhibitors

Nov. 9, 2018

Aquinnah Pharmaceuticals divulges new TDP-43 aggregation inhibitors

Nov. 9, 2018

Novintum Biotechnology presents new doxycycline derivatives for cancer

Nov. 7, 2018

Universita di Pisa patents AMPK subunit alpha-2 activators

Nov. 7, 2018

Guangzhou Wellhealth Bio-Pharmaceutical discloses PARP-1 inhibitors

Nov. 6, 2018

Novintum Biotechnology divulges azithromycin derivatives for cancer

Nov. 6, 2018

Eli Lilly identifies new EIF2AK3 inhibitors

Nov. 6, 2018

DKFZ and TUM present EPHA2 inhibitors

Nov. 6, 2018

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...